title: Plasma oxalate levels rise in hemodialysis patients despite increased oxalate removal.
abstract: The cause of secondary hyperoxalemia and oxalosis in patients on maintenance dialysis is unknown. The oxalate removal rate was determined in 26 patients on maintenance hemodialysis and 6 on continuous ambulatory peritoneal dialysis by measuring oxalate removed by dialysis and urinary excretion. The role of vitamin B6 deficiency and ascorbate in the raised plasma oxalate concentrations of these patients was evaluated. Plasma oxalate in hemodialysis patients, 442 +/- 41 micrograms/100 mL (mean +/- SE), and peritoneal patients, 394 +/- 115 micrograms/100 mL, were significantly higher than that in normal subjects, 11 +/- 1 microgram/100 mL (P less than 0.001). Average daily oxalate removal in subjects on hemodialysis, based on dialysis losses and urinary excretion, 35 +/- 3 mg/24 h, was significantly greater than urinary excretion of normal subjects, 26 +/- 1 (P less than 0.01). Oxalate removal from peritoneal dialysis patients, 28 +/- 2 mg/24 h, was not significantly different from that of hemodialysis patients or urinary excretion of normal subjects. Plasma ascorbate and B6 status were not correlated with plasma oxalate. A positive correlation between B6 deficiency and oxalate removal rate was not found. Plasma oxalate was correlated with time on dialysis (all patients) (P = 0.02). In a separate study of 15 hemodialysis patients followed over 2.3 +/- 0.2 yr, both plasma oxalate and oxalate removal rate significantly increased, P less than 0.001 and 0.05, respectively. It was concluded that oxalate removal rate is increased in hemodialysis patients and that the increased total body oxalate burden in these patients is not due to decreased removal. Although the increase may result from increased oxalate synthesis or gastrointestinal absorption, B6 deficiency and increased plasma ascorbate do not play a role.
authors.affiliation: Allegheny General Hospital/Medical College of Pennsylvania, Pittsburgh 15212.
authors.forename: J F
authors.initials: JF
authors.lastname: Costello
authors.forename: M J
authors.initials: MJ
authors.lastname: Sadovnic
authors.forename: E M
authors.initials: EM
authors.lastname: Cottington
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D001205:Ascorbic Acid / Q000097:blood; D004912:Erythrocytes / Q000201:enzymology; D006801:Humans; D007408:Intestinal Absorption; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D010070:Oxalates / Q000097:blood* / Q000378:metabolism; D019815:Oxalic Acid; D010531:Peritoneal Dialysis, Continuous Ambulatory; D006435:Renal Dialysis / Q000009:adverse effects*; D026681:Vitamin B 6 Deficiency / Q000097:blood
chemical_list: D010070:Oxalates; D019815:Oxalic Acid; D000410:Alanine Transaminase; D001205:Ascorbic Acid